Aethlon Medical Inc AEMD
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1994-03-09 |
| Shares Out. | 2,630,000 |
| Website | aethlonmedical.com/ ↗ |
| Phone | 16199410360 |
| Employees | 9 |
| Net Income | -$1.9M |
| Free Cash Flow | -$7.0M |
| Total Assets | $6.3M |
| Total Liabilities | $1.4M |
| Equity | $4.9M |
About Aethlon Medical Inc
Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.
Aethlon Medical Inc is a publicly traded company under the ticker symbol AEMD on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
7 analysts (2026-07-01)